接受维生素K拮抗剂治疗的患者长期左心室血栓溶解：评论 - Suppr

Suppr

超能文献

Long-term left ventricular thrombosis resolution in patients receiving vitamin K antagonists: comment.

作者信息

Khan Khalil Ullah, Adnan Muhammad, Qureshi Soban Ahmed, Rehman Shahrukh, Raza Sohaib

机构信息

Sharif Medical and Dental College, Lahore, Pakistan.

出版信息

Intern Emerg Med. 2025 Jul 5. doi: 10.1007/s11739-025-04041-y.

DOI:10.1007/s11739-025-04041-y

PMID:40616639

Abstract

摘要

相似文献

Long-term left ventricular thrombosis resolution in patients receiving vitamin K antagonists: comment.接受维生素K拮抗剂治疗的患者长期左心室血栓溶解：评论

Intern Emerg Med. 2025 Jul 5. doi: 10.1007/s11739-025-04041-y.

Long-term left ventricular thrombosis resolution in patients receiving vitamin k antagonists: a multicenter observational study.接受维生素K拮抗剂治疗患者的长期左心室血栓溶解：一项多中心观察性研究。

Intern Emerg Med. 2025 Apr 3. doi: 10.1007/s11739-025-03922-6.

Effect of direct oral anticoagulants versus vitamin K antagonists or warfarin in patients with left ventricular thrombus outcomes: A systematic review and meta-analysis.直接口服抗凝剂与维生素K拮抗剂或华法林对左心室血栓患者预后的影响：一项系统评价和荟萃分析。

Rev Port Cardiol. 2023 Jan;42(1):63-70. doi: 10.1016/j.repc.2021.11.013. Epub 2022 Nov 9.

Vitamin K antagonists or low-molecular-weight heparin for the long term treatment of symptomatic venous thromboembolism.维生素K拮抗剂或低分子量肝素用于有症状静脉血栓栓塞症的长期治疗。

Cochrane Database Syst Rev. 2000(4):CD002001. doi: 10.1002/14651858.CD002001.

Cochrane Database Syst Rev. 2012 Oct 17;10:CD002001. doi: 10.1002/14651858.CD002001.pub2.

Comparing clinical outcomes of vitamin K antagonists vs non-vitamin K antagonists in anticoagulant therapy for mesenteric venous thrombosis.比较抗栓治疗肠系膜静脉血栓形成中维生素 K 拮抗剂与非维生素 K 拮抗剂的临床结局。

J Vasc Surg Venous Lymphat Disord. 2024 Sep;12(5):101903. doi: 10.1016/j.jvsv.2024.101903. Epub 2024 May 15.

Cochrane Database Syst Rev. 2002(1):CD002001. doi: 10.1002/14651858.CD002001.

Evaluation of the safety and efficacy of direct oral anticoagulants compared with vitamin-k antagonists in the treatment of left ventricular thrombosis. A systematic review and meta-analysis.评价直接口服抗凝剂与维生素 K 拮抗剂治疗左心室血栓的安全性和有效性：系统评价和荟萃分析。

Heart Lung. 2024 Sep-Oct;67:121-136. doi: 10.1016/j.hrtlng.2024.04.019. Epub 2024 May 15.

Direct Oral Anticoagulants Versus Vitamin K Antagonists in the Treatment of Left Ventricular Thrombi.直接口服抗凝剂与维生素K拮抗剂治疗左心室血栓的比较

Am J Cardiovasc Drugs. 2022 May;22(3):231-238. doi: 10.1007/s40256-021-00509-2. Epub 2021 Nov 5.

Comparison of Direct Oral Anticoagulants and Vitamin K Antagonists for Left Ventricular Thrombus: A Global Retrospective Study.直接口服抗凝剂与维生素K拮抗剂治疗左心室血栓的比较：一项全球回顾性研究。

Am J Med. 2025 Mar;138(3):468-476. doi: 10.1016/j.amjmed.2024.10.042. Epub 2024 Nov 8.

本文引用的文献

Intern Emerg Med. 2025 Apr 3. doi: 10.1007/s11739-025-03922-6.

Clinical Outcome After Left Ventricular Thrombus Resolution: Who Needs Long-Term or Lifetime Use of Anticoagulants?左心室血栓溶解后的临床转归：哪些患者需要长期或终身使用抗凝药物？

J Am Heart Assoc. 2023 Apr 18;12(8):e029070. doi: 10.1161/JAHA.122.029070. Epub 2023 Apr 17.

The use of novel oral anticoagulants compared to vitamin K antagonists (warfarin) in patients with left ventricular thrombus after acute myocardial infarction.新型口服抗凝剂与维生素 K 拮抗剂（华法林）在急性心肌梗死后左心室血栓患者中的应用比较。

Eur Heart J Cardiovasc Pharmacother. 2021 Sep 21;7(5):398-404. doi: 10.1093/ehjcvp/pvaa096.

Poor Time in Therapeutic Range Control is Associated with Adverse Clinical Outcomes in Patients with Non-Valvular Atrial Fibrillation: A Report from the Nationwide COOL-AF Registry.非瓣膜性心房颤动患者治疗范围内时间控制不佳与不良临床结局相关：来自全国性COOL-AF注册研究的报告

J Clin Med. 2020 Jun 2;9(6):1698. doi: 10.3390/jcm9061698.

Anticoagulation combined with antiplatelet therapy in patients with left ventricular thrombus after first acute myocardial infarction.急性心肌梗死后首次发生左心室血栓患者的抗凝联合抗血小板治疗。

Eur Heart J. 2018 Jan 14;39(3):201-208. doi: 10.1093/eurheartj/ehx551.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验